PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-31.05%
Cash & equivalents declining -31.05% while Healthcare shows -2.59% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.
No Data
No Data available this quarter, please select a different quarter.
-31.05%
Cash + STI yoy growth ≥ 1.5x the Healthcare median of -2.89%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.05%
Exceeding 1.5x Healthcare median of 0.00%. Jim Chanos might suspect questionable capitalization or one-time items inflating current assets.
-31.37%
Current assets growth ≥ 1.5x the Healthcare median of -0.19%. Joel Greenblatt sees a potential liquidity edge if well allocated.
76.50%
PP&E growth ≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees aggressive expansion. Check if revenue growth supports it.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.08%
≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees more aggressive long-term asset growth than peers, but it must be value-accretive.
No Data
No Data available this quarter, please select a different quarter.
-30.47%
Below half the Healthcare median of 0.00%. Jim Chanos might see potential stagnation or distress vs. peers.
-21.72%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.72%
Below half Healthcare median of 2.53%. Joel Greenblatt sees more conservative short-term leverage than peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.72%
Below half Healthcare median of 0.40%. Joel Greenblatt sees a much lower liability expansion vs. peers.
0.01%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects heavier share issuance than peers.
-3.53%
≥ 1.5x Healthcare median of -1.29%. Joel Greenblatt sees stronger retained profit growth vs. peers.
-5.52%
Above 1.5x Healthcare median 0.00%. Jim Chanos suspects a red flag if these gains are highly volatile.
No Data
No Data available this quarter, please select a different quarter.
-33.13%
Below half Healthcare median of 0.00%. Jim Chanos suspects slower net worth growth or losses vs. peers.
-30.47%
Below half Healthcare median of 0.00%. Jim Chanos suspects a major slowdown or distress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.05%
Above 1.5x Healthcare median 2.34%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.